Cite
HARVARD Citation
Perkovic, V. et al. (n.d.). FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease. Nephrology dialysis transplantation. p. . [Online].